Ocugen, Inc. to Present at NobleCon18
April 19 2022 - 5:32PM
Ocugen, Inc. (NASDAQ: OCGN), a biotechnology company focused on
discovering, developing, and commercializing novel gene therapies,
biologicals and vaccines, today announces that Dr. Shankar
Musunuri, Chairman, CEO and Co-Founder of Ocugen, will present
on-location at NobleCon18 - Noble Capital Markets’ Eighteenth
Annual Investor Conference.
Event |
Noble Capital Markets’ Eighteenth Annual Investor Conference |
Date |
April 21, 2022 |
Presentation |
10:30AM Eastern Time |
On-site location |
Terrace Ballroom BHard Rock Hotel & Casino, Hollywood,
Florida |
A high-definition, video webcast of the presentation will be
available the following day on Ocugen’s website and as part of a
complete catalog of presentations available at Noble Capital
Markets’ Conference website: www.nobleconference.com and on
Channelchek www.channelchek.com the investor portal created by
Noble. The webcast will be archived on the company's website, the
NobleCon website and on Channelchek.com for 90 days following the
event.
About Ocugen, Inc.Ocugen, Inc. is a
biotechnology company focused on discovering, developing, and
commercializing novel gene therapies, biologicals and vaccines that
improve health and offer hope for people and global communities. We
are making an impact through courageous innovation, taking science
in new directions in service of patients. Our breakthrough modifier
gene therapy platform has the potential to treat multiple diseases
with one drug and we are advancing research in other therapeutic
areas to offer new options for people with unmet medical needs.
Discover more at www.ocugen.com and follow us
on Twitter and LinkedIn.
About NobleNoble Capital Markets (“Noble”) is a
research driven investment bank that has supported small &
microcap companies since 1984. As a FINRA and SEC licensed broker
dealer Noble provides institutional-quality equity research,
merchant and investment banking, and order execution services. In
2005, Noble established NobleCon, an investor conference that has
grown substantially over the last decade. Noble launched
www.channelchek.com in 2018 - an investor community dedicated
exclusively to public small and micro-cap companies and their
industries. Channelchek is the first service to offer
institutional-quality research to the public, for FREE at every
level without a subscription. More than 6,000 public emerging
growth companies are listed on the site, with growing content
including research, webcasts, podcasts, and balanced news.
Cautionary Note on Forward-Looking StatementsThis
press release contains forward-looking statements within the
meaning of The Private Securities Litigation Reform Act of 1995,
which are subject to risks and uncertainties. We may, in some
cases, use terms such as “predicts,” “believes,” “potential,”
“proposed,” “continue,” “estimates,” “anticipates,” “expects,”
“plans,” “intends,” “may,” “could,” “might,” “will,” “should” or
other words that convey uncertainty of future events or outcomes to
identify these forward-looking statements. Such statements are
subject to numerous important factors, risks and uncertainties that
may cause actual events or results to differ materially from our
current expectations. These and other risks and uncertainties are
more fully described in our periodic filings with the Securities
and Exchange Commission (“SEC”), including the risk factors
described in the section entitled “Risk Factors” in the quarterly
and annual reports that we file with the SEC. Any forward-looking
statements that we make in this press release speak only as of the
date of this press release. Except as required by law, we assume no
obligation to update forward-looking statements contained in this
press release whether as a result of new information, future events
or otherwise, after the date of this press release.
Ocugen Contact: Ken InchaustiHead,
Investor Relations & Communicationsken.inchausti@ocugen.com For
investor-related inquiries: IR@Ocugen.com
Ocugen (NASDAQ:OCGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ocugen (NASDAQ:OCGN)
Historical Stock Chart
From Apr 2023 to Apr 2024